Identification of short-chain oxidized phosphatidylcholine in human plasma

Oxidized phospholipids have been recognized as potentially important compounds that carry biological activities similar to the platelet-activating factor, but their presence in biological tissue has not been firmly established. We developed a novel technique for the quantitative analysis of phosphol...

Full description

Bibliographic Details
Main Authors: M Schlame, R Haupt, I Wiswedel, W J Kox, B Rüstow
Format: Article
Language:English
Published: Elsevier 1996-12-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520374642
_version_ 1818675649343127552
author M Schlame
R Haupt
I Wiswedel
W J Kox
B Rüstow
author_facet M Schlame
R Haupt
I Wiswedel
W J Kox
B Rüstow
author_sort M Schlame
collection DOAJ
description Oxidized phospholipids have been recognized as potentially important compounds that carry biological activities similar to the platelet-activating factor, but their presence in biological tissue has not been firmly established. We developed a novel technique for the quantitative analysis of phospholipids with oxidized acyl chains. The method involves 1) lipid extraction, 2) chromatographic enrichment of phospholipids with short acyl chains, 3) derivatization with 9-(chloromethyl)anthracene, 4) solid-phase extraction of the derivatives, and 5) reversed-phase HPLC with fluorescence detection. The technique was capable of measuring dicarboxylate-containing phosphatidylcholines (PCs) at the picomole level. The method was suited to monitor the generation of oxidized phospholipids from 1-palmitoyl-2-arachidonoyl-PC in the presence of Fe21/ascorbate. The new procedure was used to isolate lipids from human plasma that were identified as anthracene derivatives of short-chain oxidized PC on the basis of chromatographic enzymatic, and spectroscopic evidence. The plasma concentration, determined with an internal standard (1-palmitoyl-2-suberoyl-PC), was 0.6 +/- 0.2 microM (n = 11). The analytical method did not produce oxidation antifacts in significant amount. We concluded that human blood contains oxidatively fragmented PC in submicromolar concentration.
first_indexed 2024-12-17T08:30:56Z
format Article
id doaj.art-0954ecae1bce47e5b1ff0c55c67cb0ae
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T08:30:56Z
publishDate 1996-12-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-0954ecae1bce47e5b1ff0c55c67cb0ae2022-12-21T21:56:36ZengElsevierJournal of Lipid Research0022-22751996-12-01371226082615Identification of short-chain oxidized phosphatidylcholine in human plasmaM Schlame0R Haupt1I Wiswedel2W J Kox3B Rüstow4Department of Anesthesiology and Intensive Therapy, University Hospital Charité, Humboldt University, Berlin, Germany.Department of Anesthesiology and Intensive Therapy, University Hospital Charité, Humboldt University, Berlin, Germany.Department of Anesthesiology and Intensive Therapy, University Hospital Charité, Humboldt University, Berlin, Germany.Department of Anesthesiology and Intensive Therapy, University Hospital Charité, Humboldt University, Berlin, Germany.Department of Anesthesiology and Intensive Therapy, University Hospital Charité, Humboldt University, Berlin, Germany.Oxidized phospholipids have been recognized as potentially important compounds that carry biological activities similar to the platelet-activating factor, but their presence in biological tissue has not been firmly established. We developed a novel technique for the quantitative analysis of phospholipids with oxidized acyl chains. The method involves 1) lipid extraction, 2) chromatographic enrichment of phospholipids with short acyl chains, 3) derivatization with 9-(chloromethyl)anthracene, 4) solid-phase extraction of the derivatives, and 5) reversed-phase HPLC with fluorescence detection. The technique was capable of measuring dicarboxylate-containing phosphatidylcholines (PCs) at the picomole level. The method was suited to monitor the generation of oxidized phospholipids from 1-palmitoyl-2-arachidonoyl-PC in the presence of Fe21/ascorbate. The new procedure was used to isolate lipids from human plasma that were identified as anthracene derivatives of short-chain oxidized PC on the basis of chromatographic enzymatic, and spectroscopic evidence. The plasma concentration, determined with an internal standard (1-palmitoyl-2-suberoyl-PC), was 0.6 +/- 0.2 microM (n = 11). The analytical method did not produce oxidation antifacts in significant amount. We concluded that human blood contains oxidatively fragmented PC in submicromolar concentration.http://www.sciencedirect.com/science/article/pii/S0022227520374642
spellingShingle M Schlame
R Haupt
I Wiswedel
W J Kox
B Rüstow
Identification of short-chain oxidized phosphatidylcholine in human plasma
Journal of Lipid Research
title Identification of short-chain oxidized phosphatidylcholine in human plasma
title_full Identification of short-chain oxidized phosphatidylcholine in human plasma
title_fullStr Identification of short-chain oxidized phosphatidylcholine in human plasma
title_full_unstemmed Identification of short-chain oxidized phosphatidylcholine in human plasma
title_short Identification of short-chain oxidized phosphatidylcholine in human plasma
title_sort identification of short chain oxidized phosphatidylcholine in human plasma
url http://www.sciencedirect.com/science/article/pii/S0022227520374642
work_keys_str_mv AT mschlame identificationofshortchainoxidizedphosphatidylcholineinhumanplasma
AT rhaupt identificationofshortchainoxidizedphosphatidylcholineinhumanplasma
AT iwiswedel identificationofshortchainoxidizedphosphatidylcholineinhumanplasma
AT wjkox identificationofshortchainoxidizedphosphatidylcholineinhumanplasma
AT brustow identificationofshortchainoxidizedphosphatidylcholineinhumanplasma